Center for Drug Evaluation and Research growing crisis around HIV testing and treatment and an inter-agency dispute between officials from the former Bureau of Drugs and officials from the former Bureau of Biologics over whether to approve Genentech's Activase (tissue plasminogen activator) led to the split. In its original form, CDER was composed of six offices: Management, Compliance, Drug Standards, Drug Evaluation I, Drug Evaluation II, Epidemiology and Biostatistics, and Research Resources. The Division of Antiviral Products was added in 1989 under Drug Evaluation II due to the large amount of drugs proposed for treating AIDS. The Office of Generic Drugs was also formed. In 2002,
Arguments for and against drug prohibition cannabis, mescaline, and psilocybin, the medical history usually dates back thousands of years and through a variety of cultures. Psychedelics such as LSD and psilocybin (the main ingredient in most hallucinogenic mushrooms) are the subject of renewed research interest because of their therapeutic potential. They could ease a variety of difficult-to-treat mental illnesses, such as chronic depression, post-traumatic stress disorder, and alcohol dependency. MDMA (Ecstasy) has been used for cognitive enhancement in people with Parkinson's disease, and has shown potential in treating posttraumatic stress disorder. Under prohibition, millions of people find it very difficult to obtain controlled medications, particularly opiate